Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New registry monitors stent graft for blocked leg arteries

NCT ID NCT03720704

First seen Apr 17, 2026 · Last updated Apr 30, 2026 · Updated 2 times

Summary

This study is a registry that collects real-world safety and performance data on the GORE® VIABAHN® VBX Stent Graft, a device used to open blocked or narrowed blood vessels in the arms or legs. It involves 280 adults who need this treatment. The main goal is to see how well the device works and if it causes any serious side effects within 30 days.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PERIPHERAL VASCULAR DISEASES are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Azienda Ospedaliera Policlinico Sant'Orsola Malpighi

    Bologna, Italy

  • Azienda Ospedaliero-Universitaria di Padova

    Padova, Italy

  • Erasmus Medical Center

    Rotterdam, Netherlands

  • Fondazione Poliambulanza

    Brescia, Italy

  • Hospital Universitario Central de Asturias (HUCA)

    Oviedo, Spain

  • Hôpital Marie Lannelongue

    Paris, France

  • Ospedale di Circolo e Fondazione Macchi

    Varese, Italy

  • St. Franziskus Hospital

    Münster, Germany

  • University Hospital Heidelberg

    Heidelberg, Germany

  • University Hospital of Santiago de Compostela

    Santiago de Compostela, Spain

  • University Medical Center Groningen

    Groningen, Netherlands

Conditions

Explore the condition pages connected to this study.